Tag: New Product

Magstim Horizon Inspire Transcranial Magnetic Stimulation Device Approved By UKCA For NHS & Private UK Clinics UK System for Patient Treatment of MDD, OCD and Decreasing Anxiety* Carmarthenshire, UK — (December 5, 2024) – Magstim, the global leader in neuroscience research and treatment for mental health, has been awarded UKCA clearance for the Horizon Inspire … Continued

FDA Clears Magstim Horizon INSPIRE Transcranial Magnetic Stimulation System to treat Depression, OCD, Anxious Depression* Next Generation Compact TMS System Offers Physicians, Nurse Practitioners, New Easy to Use, Affordable Effective Treatment MINNEAPOLIS, Minn. & Carmarthenshire, UK — (November 12, 2024) – Magstim, the global leader in neuroscience research and treatment for mental health, has been … Continued